PMA P880090S018

Device
POLYMETHYLMETHA-CRYLATE (PMMA) INTRAOCULAR LENSES (IOLS)
Applicant
Bausch & Lomb, Inc.
PMA number
P880090
Supplement
S018
Product code
HQL
Decision date
2003-08-13
Classification
Intraocular Lens
Generic name
intraocular lens
Approval order statement
APPROVAL TO MODIFY THE DIRECTIONS FOR USE FOR ALL LEGALLY MARKETED IOLS UNDER THE REFERENCED PMAS, TO INDICATE THE IOLS FOR USE IN ADULT PATIENTS. PREVIOUSLY, THE IOLS WERE INDICATED FOR USE IN PERSONS 60 YEARS OF AGE OR OLDER. THESE DEVICES, AS MODIFIED, WILL BE MARKETED UNDER THEIR APPROVED TRADE NAMES AND ARE INDICATED FOR PRIMARY IMPLANTATION FOR THE VISUAL CORRECTION OF APHAKIA IN ADULT PATIENTS WHERE A CATARACTOUS LENS HAS BEEN REMOVED BY EXTRACAPSULAR EXTRACTION METHODS.

Current openFDA PMA Record#

Device
POLYMETHYLMETHA-CRYLATE (PMMA) INTRAOCULAR LENSES (IOLS)
Applicant
Bausch & Lomb, Inc.
PMA number
P880090
Supplement
S018
Product code
HQL
Generic name
intraocular lens
Decision date
2003-08-13
Decision code
APPR
Date received
2003-06-11
Supplement type
Real-Time Process
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Approval order statement
APPROVAL TO MODIFY THE DIRECTIONS FOR USE FOR ALL LEGALLY MARKETED IOLS UNDER THE REFERENCED PMAS, TO INDICATE THE IOLS FOR USE IN ADULT PATIENTS. PREVIOUSLY, THE IOLS WERE INDICATED FOR USE IN PERSONS 60 YEARS OF AGE OR OLDER. THESE DEVICES, AS MODIFIED, WILL BE MARKETED UNDER THEIR APPROVED TRADE NAMES AND ARE INDICATED FOR PRIMARY IMPLANTATION FOR THE VISUAL CORRECTION OF APHAKIA IN ADULT PATIENTS WHERE A CATARACTOUS LENS HAS BEEN REMOVED BY EXTRACAPSULAR EXTRACTION METHODS.